Time trends in incidence rates and survival of newly diagnosed stage IV breast cancer by tumor histology: a population-based analysis

Antonio Di Meglio, Rachel A. Freedman, Nancy U. Lin, William T. Barry, Otto Metzger-Filho, Nancy L. Keating, Tari A. King, Mario Roberto Sertoli, Francesco Boccardo, Eric P. Winer, Ines Vaz-Luis

Research output: Contribution to journalArticlepeer-review

Abstract

Few contemporary data are available that compare incidence and survival of metastatic breast cancer between ductal and lobular carcinomas. Using the Surveillance, Epidemiology, and End Results-9 registries, we identified 10,639 patients with de novo metastatic breast cancer diagnosed from 1990 to 2011. Annual age-adjusted incidence rates and annual percent changes (APCs) were analyzed. Multivariable Cox regression models were used to investigate the impact of year of diagnosis and histology on overall survival. 9250 (86.9 %) patients had ductal and 1389 (13.1 %) had lobular carcinomas. Metastatic breast cancer incidence increased slightly over time for ductal (APC = +1.7, 95 % confidence interval (CI) = +1.0 to +2.4) and lobular carcinomas (APC = +3.0, 95 % CI = +1.8 to +4.3). Median overall survival was 22 months among the whole cohort. More recent year of diagnosis was associated with better overall survival only for patients with ductal carcinomas (interaction p value = 0.006), with an adjusted hazard ratio of death for every five-year increment in the date of diagnosis of 0.93 (95 % CI = 0.91–0.95) among ductal carcinomas, compared with 1.05 (95 % CI = 0.95–1.10) among lobular carcinomas. Overall survival was longer for lobular versus ductal carcinomas (28 versus 21 months, respectively; adjusted hazard ratio of death = 0.93, 95 % CI = 0.87–0.99), but the magnitude of this effect was attenuated among the cohort restricted to hormone receptor-positive tumors. In this population-based analysis, incidence rates of metastatic breast cancer at presentation increased slightly over time for both histologies, and particularly for lobular tumors. A modest improvement in metastatic breast cancer median overall survival was observed, but was apparently limited to ductal carcinomas.

Original languageEnglish
Pages (from-to)587-596
Number of pages10
JournalBreast Cancer Research and Treatment
Volume157
Issue number3
DOIs
Publication statusPublished - Jun 1 2016

Keywords

  • Incidence
  • Invasive ductal carcinoma
  • Invasive lobular carcinoma
  • Metastatic breast cancer
  • Survival

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Time trends in incidence rates and survival of newly diagnosed stage IV breast cancer by tumor histology: a population-based analysis'. Together they form a unique fingerprint.

Cite this